農村インド人女性における心血管疾患リスクの個別化予測のための臨床的および生化学的データの活用:精密栄養に向けた機械学習アプローチ
Joyeta Ghosh1, Tinni Chaudhuri2, Jose Arturo Molina Mora3
1Department of Dietetics and Applied Nutrition, Amity Institute of Applied Sciences (AIAS), Amity University - Kolkata Campus, Major Arterial Road, Action Area II, KadampukurVillage,Rajarhat, Newtown, Kolkata, West Bengal 700135, India.
Background:
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality among postmenopausal women in rural India, where healthcare resources remain limited. This study aimed to leverage artificial intelligence (AI) and machine learning (ML) approaches to predict CVD risk in rural elderly women, identify key clinical predictors, and assess model performance using interpretable AI tools.
Methods:
This observational cross-sectional study was conducted in Singur Block (West Bengal) and Amdanga Block (North 24 Parganas District) between March 2014 and August 2018. Data from 458 rural postmenopausal women were analyzed. The outcome variable was the presence or absence of elevated cardiovascular disease risk, defined using composite International Diabetes Federation (IDF) and American Heart Association (AHA) criteria. Predictors included waist circumference, blood pressure, fasting blood glucose, HDL cholesterol, triglycerides, and vitamin D levels. Seven ML models (including Random Forest, Gradient Boosting, Ensemble (Voting Classifier), Extra Trees, Support Vector Machine (SVM), Neural Network, and Logistic Regression) were developed and compared. Model evaluation employed 5-fold cross-validation with metrics including accuracy, AUC, precision, recall, and F1-score.
Results:
Among the 458 participants, 171 (37.3%) exhibited elevated CVD risk. The Random Forest model achieved an accuracy of 98.91% (95% CI: 97.8-99.6%), while XGBoost demonstrated comparable performance with an AUC of 0.998 (95% CI: 0.993-1.000), precision of 97.2%, and recall of 98.3%. Feature importance analysis revealed waist circumference, blood pressure, and fasting glucose as the strongest predictors, with HDL and vitamin D contributing modestly but significantly.
Conclusion:
Machine learning models-particularly Random Forest and XGBoost-demonstrated high accuracy and interpretability in predicting CVD risk among rural postmenopausal women. These findings highlight the potential of AI-driven, low-cost predictive tools for early CVD risk detection and personalized preventive healthcare in resource-limited rural settings. Registration and Ethical Compliance: This study was approved by the Institutional Ethical Committee of the All India Institute of Hygiene and Public Health (AIIH&PH), Kolkata (Approval No: AIIH/IEC/2014/27). As this was an observational, non-interventional study, no clinical trial registration was required.
さらに関連する動画
07:51Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
Published on: September 26, 2018
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
関連する概念動画
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
